Novartis backs $30M round for cancer biotech; Bayer drug makes a 'breakthrough' at FDA - Endpoints News https://t.co/0G0VUw673b
— IDRO (@IDROOhio) May 30, 2019
from Twitter https://twitter.com/IDROOhio
May 29, 2019 at 10:02PM
Thursday, May 30, 2019
Novartis backs $30M round for cancer biotech; Bayer drug makes a 'breakthrough' at FDA - Endpoints News https://t.co/0G0VUw673b
from Twitter https://twitter.com/IDROOhio
May 29, 2019 at 10:02PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment